Melanie M. Scully, Ph.D. - Publications

Affiliations: 
2014 Molecular Biology University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Molecular Biology, Cell Biology, Oncology

13/30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Scully MM, Palacios-Helgeson LK, Wah LS, Jackson TA. Rapid estrogen signaling negatively regulates PTEN activity through phosphorylation in endometrial cancer cells. Hormones & Cancer. 5: 218-31. PMID 24844349 DOI: 10.1007/S12672-014-0184-Z  0.389
2014 Campbell EL, Bruyninckx WJ, Kelly CJ, Glover LE, McNamee EN, Bowers BE, Bayless AJ, Scully M, Saeedi BJ, Golden-Mason L, Ehrentraut SF, Curtis VF, Burgess A, Garvey JF, Sorensen A, et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity. 40: 66-77. PMID 24412613 DOI: 10.1016/J.Immuni.2013.11.020  0.397
2014 Weissmüller T, Glover LE, Fennimore B, Curtis VF, MacManus CF, Ehrentraut SF, Campbell EL, Scully M, Grove BD, Colgan SP. HIF-dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 256-64. PMID 24029533 DOI: 10.1096/Fj.13-238741  0.347
2011 Kominsky DJ, Keely S, MacManus CF, Glover LE, Scully M, Collins CB, Bowers BE, Campbell EL, Colgan SP. An endogenously anti-inflammatory role for methylation in mucosal inflammation identified through metabolite profiling. Journal of Immunology (Baltimore, Md. : 1950). 186: 6505-14. PMID 21515785 DOI: 10.4049/Jimmunol.1002805  0.389
2011 Glover LE, Irizarry K, Scully M, Campbell EL, Bowers BE, Aherne CM, Kominsky DJ, MacManus CF, Colgan SP. IFN-γ attenuates hypoxia-inducible factor (HIF) activity in intestinal epithelial cells through transcriptional repression of HIF-1β. Journal of Immunology (Baltimore, Md. : 1950). 186: 1790-8. PMID 21199896 DOI: 10.4049/jimmunol.1001442  0.318
2011 Kominsky D, Keely S, MacManus C, Glover L, Scully M, Collins C, Bowers B, Campbell E, Colgan S. Cellular methylation plays an anti-inflammatory role in Mucosal Inflammation Inflammatory Bowel Diseases. 17: S85. DOI: 10.1097/00054725-201112002-00282  0.353
2011 Kominsky D, Keely S, Campbell E, Christopher M, Scully M, Collins C, Bowers B, Colgan S. A central role of methylation in mucosal inflammation. Inflammatory Bowel Diseases. 17: S23-S23. DOI: 10.1093/Ibd/17.Supplement1.S23A  0.314
2010 Campbell EL, MacManus CF, Kominsky DJ, Keely S, Glover LE, Bowers BE, Scully M, Bruyninckx WJ, Colgan SP. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Proceedings of the National Academy of Sciences of the United States of America. 107: 14298-303. PMID 20660763 DOI: 10.1093/Ibd/17.Supplement1.S13A  0.359
2010 Hirota SA, Fines K, Ng J, Traboulsi D, Lee J, Ihara E, Li Y, Willmore WG, Chung D, Scully MM, Louie T, Medlicott S, Lejeune M, Chadee K, Armstrong G, et al. Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury. Gastroenterology. 139: 259-69.e3. PMID 20347817 DOI: 10.1053/J.Gastro.2010.03.045  0.31
2009 Frick JS, MacManus CF, Scully M, Glover LE, Eltzschig HK, Colgan SP. Contribution of adenosine A2B receptors to inflammatory parameters of experimental colitis. Journal of Immunology (Baltimore, Md. : 1950). 182: 4957-64. PMID 19342675 DOI: 10.4049/Jimmunol.0801324  0.374
2009 Keely S, Glover LE, MacManus CF, Campbell EL, Scully MM, Furuta GT, Colgan SP. Selective induction of integrin beta1 by hypoxia-inducible factor: implications for wound healing. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 1338-46. PMID 19103643 DOI: 10.1096/Fj.08-125344  0.357
2008 Weissmüller T, Campbell EL, Rosenberger P, Scully M, Beck PL, Furuta GT, Colgan SP. PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. The Journal of Clinical Investigation. 118: 3682-92. PMID 18924612 DOI: 10.1172/Jci35874  0.323
2007 Kong T, Scully M, Shelley CS, Colgan SP. Identification of Pur alpha as a new hypoxia response factor responsible for coordinated induction of the beta 2 integrin family. Journal of Immunology (Baltimore, Md. : 1950). 179: 1934-41. PMID 17641060 DOI: 10.4049/Jimmunol.179.3.1934  0.307
Low-probability matches (unlikely to be authored by this person)
2011 Campbell E, MacManus C, Kominsky D, Keely S, Glover L, Bowers B, Scully M, Bruyninckx W, Colgan S. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification. Inflammatory Bowel Diseases. 17: S13-S13. DOI: 10.1093/ibd/17.supplement1.s13a  0.264
2007 Louis NA, Robinson AM, Karhausen J, Scully M, Colgan SP. Control of Interferon‐alphaA by CD73: Implications for Mucosal Inflammation The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A131  0.243
2009 Gerich M, Kominsky D, Scully M, Colgan S. Interleukin-10 selectively regulates HIF-1a function in intestinal epithelial cells through regulated expression of HIF Prolyl Hydroxylases Inflammatory Bowel Diseases. 15: S51-S52. DOI: 10.1097/00054725-200912002-00159  0.237
2008 Louis NA, Robinson AM, MacManus CF, Karhausen J, Scully M, Colgan SP. Control of IFN-alphaA by CD73: implications for mucosal inflammation. Journal of Immunology (Baltimore, Md. : 1950). 180: 4246-55. PMID 18322237 DOI: 10.4049/jimmunol.180.6.4246  0.154
2001 Dowd NP, Scully M, Adderley SR, Cunningham AJ, Fitzgerald DJ. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo Journal of Clinical Investigation. 108: 585-590. PMID 11518732 DOI: 10.1172/JCI11334  0.124
2024 Alleva DG, Feitsma EA, Janssen YF, Boersma HH, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, et al. Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine. Npj Vaccines. 9: 40. PMID 38383578 DOI: 10.1038/s41541-024-00830-2  0.12
1992 Dykstra KH, Hsiao JK, Morrison PF, Bungay PM, Mefford IN, Scully MM, Dedrick RL. Quantitative examination of tissue concentration profiles associated with microdialysis Journal of Neurochemistry. 58: 931-940. PMID 1738000  0.098
2021 Alleva DG, Delpero AR, Scully MM, Murikipudi S, Ragupathy R, Greaves EK, Sathiyaseelan T, Haworth JR, Shah NJ, Rao V, Nagre S, Lancaster TM, Webb SS, Jasa AI, Ronca SE, et al. Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. PMID 34642088 DOI: 10.1016/j.vaccine.2021.09.077  0.096
2022 Janssen YF, Feitsma EA, Boersma HH, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, et al. Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452. Vaccine. 40: 1253-1260. PMID 35115195 DOI: 10.1016/j.vaccine.2022.01.043  0.091
1995 Garland A, Jordan JE, Necheles J, Alger LE, Scully MM, Miller RJ, Ray DW, White SR, Solway J. Hypertonicity, but not hypothermia, elicits substance P release from rat C-fiber neurons in primary culture. The Journal of Clinical Investigation. 95: 2359-66. PMID 7537764 DOI: 10.1172/JCI117928  0.082
2023 Feitsma EA, Janssen YF, Boersma HH, van Sleen Y, van Baarle D, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, et al. A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452. Vaccine. PMID 36842886 DOI: 10.1016/j.vaccine.2023.02.057  0.05
2008 Kakkos SK, Haddad GK, Haddad JA, Scully MM. Secondary Patency of Thrombosed Prosthetic Vascular Access Grafts with Aggressive Surveillance, Monitoring and Endovascular Management European Journal of Vascular and Endovascular Surgery. 36: 356-365. PMID 18603454 DOI: 10.1016/j.ejvs.2008.05.007  0.037
2008 Kakkos SK, Haddad GK, Haddad J, Scully MM. Percutaneous rheolytic thrombectomy for thrombosed autogenous fistulae and prosthetic arteriovenous grafts: Outcome after aggressive surveillance and endovascular management Journal of Endovascular Therapy. 15: 91-102. PMID 18254668 DOI: 10.1583/07-2239.1  0.037
2008 Kakkos SK, Haddad GK, Haddad RK, Scully MM. Effectiveness of a new tunneled catheter in preventing catheter malfunction: a comparative study. Journal of Vascular and Interventional Radiology : Jvir. 19: 1018-26. PMID 18589315 DOI: 10.1016/j.jvir.2008.03.006  0.027
2008 Kakkos SK, Andrzejewski T, Haddad JA, Haddad GK, Reddy DJ, Nypaver TJ, Scully MM, Schmid DL. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment Journal of Vascular Surgery. 47: 407-414. PMID 18155874 DOI: 10.1016/j.jvs.2007.09.061  0.025
2013 Brotherton JM, Murray SL, Hall MA, Andrewartha LK, Banks CA, Meijer D, Pitcher HC, Scully MM, Molchanoff L. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. The Medical Journal of Australia. 199: 614-7. PMID 24182228 DOI: 10.5694/mja13.10272  0.012
2010 Kakkos SK, Haddad GK, Weaver MR, Haddad RK, Scully MM. Basilic vein transposition: what is the optimal technique? European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society For Vascular Surgery. 39: 612-9. PMID 20172751 DOI: 10.1016/j.ejvs.2010.01.006  0.01
Hide low-probability matches.